chr4-24799572-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003102.4(SOD3):c.51C>A(p.Asp17Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000686 in 1,602,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003102.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOD3 | NM_003102.4 | c.51C>A | p.Asp17Glu | missense_variant | 2/2 | ENST00000382120.4 | NP_003093.2 | |
SOD3 | XR_427488.2 | n.146C>A | non_coding_transcript_exon_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOD3 | ENST00000382120.4 | c.51C>A | p.Asp17Glu | missense_variant | 2/2 | 1 | NM_003102.4 | ENSP00000371554 | P1 | |
SOD3 | ENST00000598411.1 | c.51C>A | p.Asp17Glu | missense_variant | 3/3 | 5 | ENSP00000472134 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000438 AC: 1AN: 228370Hom.: 0 AF XY: 0.00000794 AC XY: 1AN XY: 125966
GnomAD4 exome AF: 0.00000621 AC: 9AN: 1450296Hom.: 0 Cov.: 31 AF XY: 0.00000554 AC XY: 4AN XY: 721666
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2023 | The c.51C>A (p.D17E) alteration is located in exon 2 (coding exon 1) of the SOD3 gene. This alteration results from a C to A substitution at nucleotide position 51, causing the aspartic acid (D) at amino acid position 17 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at